The Carcinoid Tumor Panel Test is a sophisticated diagnostic tool designed to detect and analyze specific markers associated with carcinoid tumors. Carcinoid tumors are a type of neuroendocrine tumor that usually grow slowly and can occur in various parts of the body, but most commonly in the gastrointestinal tract or the lungs. These tumors can produce and release hormones into the bloodstream, leading to a range of symptoms, including flushing, diarrhea, and wheezing, depending on the location and size of the tumor.
The test aims to provide comprehensive insights into the genetic makeup of the tumor, helping healthcare professionals in making accurate diagnoses, determining the prognosis, and tailoring personalized treatment plans for patients. By evaluating a panel of genes and biomarkers associated with carcinoid tumors, this test can also aid in identifying potential therapeutic targets, thereby optimizing treatment strategies.
Offered by DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates, the Carcinoid Tumor Panel Test is priced at 2340 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by a team of highly skilled professionals, ensuring that patients receive reliable and accurate test results. The cost of the test reflects the intricate technology and expertise required to analyze the genetic and molecular components of carcinoid tumors.
For patients suspected of having a carcinoid tumor or those undergoing treatment, this panel test represents a critical step towards understanding their condition better and managing it effectively.
Chimerism Pre-engraftment Donor and Recipient Test is a crucial diagnostic procedure performed to evaluate the success of bone marrow or stem cell transplants by analyzing the coexistence of donor and recipient cells in the patient's body. This test helps in monitoring and managing the patient's condition post-transplant, ensuring that the donor cells are properly engrafting and functioning within the recipient's body. It plays a significant role in predicting potential complications, such as graft-versus-host disease (GVHD), and in making informed decisions regarding the patient's treatment plan.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test offers a detailed insight into the chimeric status of an individual post-transplantation. By utilizing advanced genetic analysis techniques, DNA Labs UAE ensures accurate and reliable results, which are crucial for the ongoing care and management of transplant recipients.
The cost of the Chimerism Pre-engraftment Donor and Recipient Test at DNA Labs UAE is 2340 AED. This investment is vital for the meticulous monitoring required during the critical early stages post-transplant, enabling healthcare providers to optimize outcomes for their patients through personalized treatment adjustments based on the test results.
Hepatitis B Viral Drug Resistance and Genotyping Test is a critical diagnostic tool used in the management and treatment of Hepatitis B virus (HBV) infections. This test is designed to identify mutations in the HBV genome that can lead to resistance against antiviral drugs. By understanding the genetic makeup of the virus, healthcare providers can tailor treatment plans to effectively combat the infection and reduce the risk of drug resistance. The genotyping aspect of the test further helps in determining the specific strain of HBV, which can influence the choice of treatment and provide insights into the prognosis of the infection.
The test is available at DNA Labs UAE, a leading facility known for its advanced diagnostic services. The cost of the Hepatitis B Viral Drug Resistance and Genotyping Test is set at 2340 AED. This investment is crucial for individuals diagnosed with HBV, as it guides the selection of the most effective therapeutic strategies, potentially leading to better health outcomes and minimizing the risk of liver disease progression.
The "HLA DSA Donor Specific IgG Antibodies Class I and II Test" is a sophisticated diagnostic procedure available at DNA Labs UAE, designed to assess the presence of donor-specific antibodies (DSAs) in patients who have received organ transplants. This test specifically focuses on identifying IgG antibodies that target Class I and II Human Leukocyte Antigen (HLA) molecules. The presence of these antibodies can indicate an immune response against the transplanted organ, potentially leading to graft rejection. Therefore, this test is crucial for monitoring transplant compatibility and the long-term success of the transplantation.
The procedure involves a detailed analysis of the patient's blood sample to detect and quantify the DSAs, providing essential information for managing post-transplant care effectively. By identifying these antibodies early, clinicians can adjust immunosuppressive therapy accordingly to improve transplant outcomes and patient well-being.
The cost of the HLA DSA Donor Specific IgG Antibodies Class I and II Test at DNA Labs UAE is 2340 AED. Given the complexity and the critical nature of the information it provides, the test represents a valuable tool in the management of transplant patients, ensuring that personalized treatment plans can be developed and adjusted as necessary to protect the transplanted organ from immune-mediated damage.
The HLA T and B Cell Flow Cytometry Crossmatch Test is a sophisticated diagnostic procedure used to evaluate the compatibility between donor and recipient tissues prior to organ transplantation. This test is crucial in detecting the presence of antibodies in the recipient's blood that might react against the donor's human leukocyte antigens (HLA), which are markers found on the surface of cells. By specifically analyzing both T lymphocytes (T cells) and B lymphocytes (B cells), the test provides a comprehensive assessment of potential immune responses that could lead to transplant rejection.
Performed at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, the test employs state-of-the-art flow cytometry technology. This technology allows for the precise and detailed analysis of multiple parameters of individual cells in a fluid as they pass by a laser, making it possible to detect even low levels of antibodies against donor HLA.
The cost of the HLA T and B Cell Flow Cytometry Crossmatch Test at DNA Labs UAE is 2340 AED. This price reflects the advanced technology and expertise required to perform such a detailed immune assessment, ensuring that patients receive the most accurate compatibility results before undergoing transplant procedures.
The HLA T and B Cell Lymphocyte Crossmatch Test is a crucial diagnostic procedure used to evaluate compatibility between organ donors and recipients, ensuring the success of transplants and minimizing the risk of rejection. This test specifically examines the interaction between the Human Leukocyte Antigen (HLA) molecules of the donor and the recipient's T and B lymphocytes, which are key components of the immune system. By identifying potential harmful reactions between the donor's organ and the recipient's immune cells, healthcare providers can make informed decisions about proceeding with transplantation.
Performed at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, the test offers accurate and reliable results. The cost of the HLA T and B Cell Lymphocyte Crossmatch Test is set at 2000 AED, reflecting the sophisticated technology and expertise required to conduct this specialized analysis. By investing in this test, patients and medical teams can significantly enhance the likelihood of transplant success, paving the way for improved health outcomes.
The "IMD Panel Extended Test" is a comprehensive diagnostic procedure conducted at DNA Labs UAE, designed to screen for a wide array of Inborn Errors of Metabolism (IMDs). This advanced testing panel aims to identify genetic metabolic disorders that can affect an individual's health from a very early age, facilitating timely intervention and management. With a test cost of 2000 AED, the IMD Panel Extended Test provides a valuable resource for healthcare professionals and families seeking to understand potential metabolic issues, ensuring that appropriate treatments and dietary adjustments can be made to improve patient outcomes. DNA Labs UAE, with its state-of-the-art facilities and expert team, ensures accurate and reliable results, making it a trusted choice for genetic and metabolic screening in the region.
The KIR Genotyping Test, available at DNA Labs UAE for a cost of 2340 AED, is a specialized diagnostic procedure designed to analyze the KIR (Killer-cell Immunoglobulin-like Receptors) genes. These genes play a crucial role in the immune system by regulating the activity of natural killer (NK) cells, which are essential for the body's defense against tumors and virally infected cells. By determining the specific variations and types of KIR genes present in an individual, this test provides valuable insights into one's immune system functionality and potential susceptibility to various diseases, including autoimmune disorders and certain types of cancer. The results from the KIR Genotyping Test can also be instrumental in transplant medicine, particularly in bone marrow or stem cell transplantation, by helping to predict transplant success and the risk of graft-versus-host disease. Conducted at the state-of-the-art facilities of DNA Labs UAE, the test is a significant tool for both medical research and personalized medicine, aiding in the development of tailored treatments and therapeutic strategies.
The NOTCH3 Mutation Detection CADASIL Test is a specialized genetic test conducted to identify mutations in the NOTCH3 gene, which are associated with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL). CADASIL is a rare genetic disorder that leads to damage to the small blood vessels in the brain, contributing to a range of neurological symptoms such as migraines, cognitive decline, strokes, and mood disturbances. Early detection through the NOTCH3 Mutation Detection CADASIL Test can aid in the diagnosis and management of the condition, potentially improving the quality of life for affected individuals and their families.
The test is available at DNA Labs UAE, a reputable genetic testing facility known for its advanced diagnostic technologies and expert medical staff. The cost of the test is 2340 AED, making it a valuable investment for individuals with a family history of CADASIL or those exhibiting symptoms related to the disorder. By opting for this test at DNA Labs UAE, patients can expect accurate, reliable results and comprehensive support throughout the testing process, enabling informed healthcare decisions and personalized management strategies for CADASIL.
The Oxalate Test is a specialized diagnostic procedure designed to measure the concentration of oxalates in the body, which are organic compounds found in many plants, vegetables, and fruits. High levels of oxalates can lead to the formation of kidney stones and other health issues, making this test crucial for individuals experiencing related symptoms or those with a history of kidney stones. Priced at 2340 AED, the test is available at DNA Labs UAE, a reputable facility known for its advanced diagnostic services. DNA Labs UAE utilizes state-of-the-art technology to ensure accurate and reliable results, providing essential insights into a patient's oxalate levels to aid in the diagnosis, treatment, and management of conditions associated with high oxalate concentrations.
